What are the latest guidelines for managing sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Latest Guidelines for Managing Sepsis

The latest sepsis management guidelines recommend administering broad-spectrum antibiotics within 1 hour of recognition, providing at least 30 mL/kg crystalloid fluid resuscitation for hypotension or lactate ≥4 mmol/L within the first 3 hours, and implementing early vasopressor therapy (norepinephrine as first-line) for persistent hypotension. 1

Initial Assessment and Resuscitation

Diagnosis and Initial Steps

  • Obtain blood cultures before starting antibiotics (within 45 minutes) 1
  • Order appropriate imaging studies to identify the infection source 1
  • Administer broad-spectrum antibiotics within 1 hour covering gram-positive, gram-negative, and anaerobic organisms 1
  • Consider 1,3 β-D-glucan assay, mannan and anti-mannan antibody assays if invasive candidiasis is suspected 1

Fluid Resuscitation

  • Administer at least 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L within first 3 hours 1
  • Continue fluid challenges as long as hemodynamic improvement occurs 1

Hemodynamic Support

  • Target specific resuscitation goals within 6 hours:
    • Mean arterial pressure (MAP) ≥65 mmHg
    • Urine output ≥0.5 mL/kg/h
    • Central venous oxygen saturation ≥70% or mixed venous oxygen saturation ≥65%
    • Normalization of lactate if initially elevated 1
  • Use norepinephrine as first-line vasopressor for persistent hypotension 1
  • Consider adding epinephrine or vasopressin to norepinephrine if needed 1
  • Avoid dopamine except in highly selected circumstances 1

Source Control and Antimicrobial Management

Source Control

  • Promptly identify and control infection source through imaging studies 1
  • Perform necessary interventions: drain abscesses, remove infected devices, relieve obstructions 1

Antimicrobial Management

  • Reassess antimicrobial therapy daily 1
  • De-escalate to targeted therapy once culture results are available (48-72 hours) 1
  • For patients on continuous renal replacement therapy (CRRT), standard recommended doses may be inadequate for certain antibiotics (particularly cefepime, ceftazidime, and piperacillin-tazobactam) 2

Supportive Care Measures

Mechanical Ventilation

  • Target tidal volume of 6 mL/kg predicted body weight in patients with sepsis-induced ARDS 3
  • Keep plateau pressures ≤30 cm H2O 3
  • Apply positive end-expiratory pressure (PEEP) to avoid alveolar collapse 3
  • Consider prone positioning for severe refractory hypoxemia (PaO2/FIO2 ratio ≤100 mmHg) 3
  • Elevate head of bed to 30-45 degrees 3
  • Implement weaning protocols when appropriate 3

Blood Products Management

  • Transfuse red blood cells when hemoglobin <7.0 g/dL (target 7.0-9.0 g/dL) once tissue hypoperfusion has resolved 3
  • Do not use erythropoietin for anemia treatment 3
  • Avoid fresh frozen plasma to correct laboratory clotting abnormalities unless bleeding or invasive procedures planned 3
  • Administer platelets prophylactically when counts <10,000/mm³ without bleeding, or <20,000/mm³ with significant bleeding risk 3

Corticosteroids

  • Do not routinely use IV hydrocortisone if adequate fluid resuscitation and vasopressor therapy restore hemodynamic stability 3
  • Consider IV hydrocortisone (200 mg/day) if hemodynamic stability cannot be achieved 3
  • Do not use adrenocorticotropic hormone stimulation test to guide hydrocortisone therapy 3
  • Taper hydrocortisone when vasopressors are no longer required 3

Monitoring and Additional Care

Monitoring Parameters

  • Monitor lactate clearance, urine output, mental status, capillary refill time, and vital signs 1
  • Use qSOFA score (respiratory rate ≥22/min, altered mental status, systolic BP ≤100 mmHg) and full SOFA score for ICU patients to assess severity 1

Additional Supportive Measures

  • Provide DVT and stress ulcer prophylaxis 1
  • Implement glycemic control with target upper blood glucose ≤180 mg/dL 1
  • Provide adequate nutritional support (20-30 kcal/kg/day) 1

Common Pitfalls and Caveats

  • Delayed antibiotic administration is associated with decreased survival (approximately 7.6% per hour) 1
  • Insufficient fluid resuscitation can worsen organ perfusion 1
  • Inadequate source control and inappropriate antimicrobial de-escalation should be avoided 1
  • Standard antibiotic dosing may be insufficient for patients on CRRT, particularly for cefepime, ceftazidime, and piperacillin-tazobactam; consider higher doses or extended infusions 2
  • The inflammatory response in sepsis can be mimicked by other conditions such as anaphylaxis, pulmonary disease, metabolic abnormalities, and toxin ingestion/withdrawal, requiring careful differential diagnosis 4

References

Guideline

Sepsis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.